Treatment of early breast cancer, a long-term follow-up study: The GOCS experience

Breast Journal

Volumn 17, Issue 6, 2011, Pages 630-637

  Iturbe, Julián ^a   Zwenger, Ariel ^a   Leone, José Pablo ^b   Verdera, Palmira Perez ^a   Vallejo, Carlos ^a   Romero, Alberto ^a   Perez, Juán ^a   MacHiavelli, Mario ^a   Leone, Bernardo ^a  

^a Grupo Oncologico Cooperativo del Sur   (Argentina)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

breast cancer; breast cancer demographics; early breast cancer; long term follow up; overall survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CONTROLLED STUDY; DISEASE FREE INTERVAL; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 80755168334     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01157.x     Document Type: Article

References (32)

1. Greene FL, Page DL, Fleming ID, et al. (eds) AJCC Cancer Staging Handbook: TNM Classification of Malignant Tumours, 6th edn. New York: John Wiley & Sons, 2002.
2. Luke C, Nguyen AM, Priest K, et al. Female breast cancers are getting smaller, but sociodemographic differences remain. Aust N Z J Public Health 2004; 28: 312-6. (Pubitemid 40125269)
3. Fracheboud J, Otto SJ, van Dijck JA, et al. National Evaluation Team for Breast Cancer Screening (NETB): decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 2004; 91: 861-7. (Pubitemid 39273776)
4. Cazap E, Buzaid A, Garbino C, et al. Breast cancer in Latin America: experts perceptions compared with medical care standards. Cancer 2008; 113 (8 Suppl): 2359-65.
5. Vacek PM, Geller BM, Weaver DL, et al. Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999. Cancer 2002; 94: 2160-8. (Pubitemid 34411972)
6. Schootman M, Jeffe D, Reschke A, et al. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat 2004; 85: 219-22. (Pubitemid 38987255)
7. Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN,. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature. J Clin Oncol 2006; 13: 2113-22. (Pubitemid 46628472)
8. Schwartsmann G,. Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol 2001; 19 (18 Suppl): 118S-24S. (Pubitemid 32880094)
9. Rabinovich MG, Vallejo CT, Perez JE, et al. Impact of delay to treatment upon survival in 1067 patients with breast cancer. Int J Oncol 1993; 2: 197-201. (Pubitemid 23043340)
10. Robbins GF, Bross I,. The significance of delay in relation to prognosis of patients with primary operable breast cancer. Cancer 1957; 10: 338-44.
11. Dennis CR, Gardner B, Lim B,. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer 1975; 35: 714-20.
12. Vernon SW, Tilley BC, Neale AV, Steinfeldt L,. Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 1985; 55: 1563-71. (Pubitemid 15140695)
13. Charlson ME,. Delay in the treatment of carcinoma of the breast. Surg Gynecol Obstet 1985; 160: 393-9. (Pubitemid 15057828)
14. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD,. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999; 79: 858-64. (Pubitemid 29082117)
15. Sainsbury R, Johnston C, Haward B,. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999; 353: 1132-5. (Pubitemid 29155205)
16. Unger-Saldaña K, Infante-Castañeda C,. Delay of medical care for symptomatic breast cancer: a literature review. Salud Publica Mex 2009; 51 (Suppl 2): s270-85.
17. Menke CH, Pohlmann PR, Backes A, et al. Tumor size as a surrogate end point for the detection of early breast cancer: a 30-year (1972-2002), single-center experience in southern Brazil. Breast J 2007; 13: 448-56. (Pubitemid 47329331)
18. Elkin EB, Hudis C, Begg CR, Schrag D,. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999. Cancer 2005; 104: 1149-57. (Pubitemid 41278949)
19. Kerlikowske K,. Efficacy of screening mammography. A meta-analysis. JAMA 1995; 273: 149-54.
20. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: uptdate international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16: 1569-83. (Pubitemid 41511089)
21. Weiss RB, Woolf SH, Demakos E, et al. Cancer and Leukemia Group B. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. J Clin Oncol 2003; 21: 1825-35. (Pubitemid 46638596)
22. Bonadonna G, Moliterni A, Zambetti M, et al. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 2005; 330: 217.
23. Valagussa P, Tancini G, Bonadonna G,. Second malignancies after CMF for resectable breast cancer. J Clin Oncol 1987; 5: 1138-42. 1975-1999. Cancer 2005; 104: 1149-57 (Pubitemid 18045297)
24. 1975-1999. Cancer 2005; 104: 1149-57
25. Carter CL, Allen C, Henson D,. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-7. (Pubitemid 19032001)
26. Gebauer G, Fehm T, Lang N, et al. Tumor size,axillary nodal status and steroid receptor expression in breast cancer: prognostic relevance 5 years after surgery. Breast Cancer Res Treat 2002; 75: 167-73. (Pubitemid 34994952)
27. Blichert-Toft M, Nielsen M, Dü Ring M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 2008; 47: 672-81. (Pubitemid 351878447)
28. Rutqvist LE, Hemming J,. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients. Acta Oncol 2006; 45: 517-27.
29. Van der Sangen MJ, van de Wiel FM, Poortmans PM, et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged
30. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW,. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 361: 1405-10. (Pubitemid 36515039)
31. Elmore JG, Reisch LM, Barton MB, et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 2005; 97: 1035-43. (Pubitemid 41417920)
32. Mette Kalager, Marvin Zelen, Frçydis Langmark, Hans-Olov Adami,. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010; 363: 1203-10.